Cedexis Inc.
CDXS US1920051067
Codexis Inc is involved in the business of providing enzyme optimization services, commercialization of proteins, and developing biocatalyst products, leveraging its proprietary CodeEvolver directed evolution technology platform. The firm's products and services include Biocatalysts and Enzymes. The company generates majority of its revenue through product sales and also licenses its technology platform CodeEvolver to pharmaceutical companies enabling them to use this technology, in-house, to engineer enzymes for their own businesses. Geographically, it derives revenue from the United States, Ireland, Switzerland, China and other markets.
Annual Performance 1
2021 | 2022 | 2023 | 2024 | 2025 |
---|---|---|---|---|
46% | -85% | -35% | 53% | 0% |
Annual Insiders Turnover, USD 2
1 annual and historical performance metrics are recalculated on a daily basis;
2 represents the total value of insider transactions (both buying and selling);
Insider Activity
Person | Price | Shares | Total | Published | Completed |
---|---|---|---|---|---|
Opaleye Management Inc. O |
2.84 USD |
780 Bought |
2,211 USD |
31/07/2025 | 04/08/2025 |
Opaleye Management Inc. O |
2.68 USD |
84,220 Bought |
225,710 USD |
31/07/2025 | 31/07/2025 |
Opaleye Management Inc. O |
2.80 USD |
1,578 Bought |
4,411 USD |
29/07/2025 | 30/07/2025 |
Opaleye Management Inc. O |
2.82 USD |
8,422 Bought |
23,750 USD |
29/07/2025 | 29/07/2025 |
Opaleye Management Inc. O |
2.82 USD |
100,000 Bought |
282,000 USD |
18/07/2025 | 18/07/2025 |
Opaleye Management Inc. O |
2.39 USD |
100,000 Bought |
239,000 USD |
27/06/2025 | 27/06/2025 |
Opaleye Management Inc. O |
2.24 USD |
50,898 Bought |
114,012 USD |
12/06/2025 | 16/06/2025 |
Opaleye Management Inc. O |
2.23 USD |
99,102 Bought |
220,997 USD |
12/06/2025 | 13/06/2025 |
Opaleye Management Inc. O |
2.25 USD |
100,000 Bought |
225,000 USD |
12/06/2025 | 12/06/2025 |
Opaleye Management Inc. O |
2.36 USD |
5,000 Bought |
11,800 USD |
23/05/2025 | 28/05/2025 |